• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Business»Drugs and privilege: Big business, Congress and the EpiPen

Drugs and privilege: Big business, Congress and the EpiPen

Saheli 31 Aug 2016 Business Comments Off on Drugs and privilege: Big business, Congress and the EpiPen 676 Views

Drugs and privilege: Big business, Congress and the EpiPen

This piece originally appeared on BillMoyers.com.

Cash and carry has become nothing more than standard operating procedure in politics and government, and it’s wrecking the republic. The whole system is rotten to the core, corrupted by big business and special interests from the seventh son to the seventh son.

Or daughter, as we learned these past few days when the news introduced us to Heather Bresch, CEO of a drug company called Mylan and daughter of Democratic U.S. Sen. Joe Manchin III, who’s also the former governor of West Virginia.

Mylan manufactures and sells EpiPen, the emergency delivery system for an allergy drug, epinephrine, that can make the difference between life and sudden death. The cost for a two-pack of the devices has soared nearly 550 percent to $608.61. That’s a price far beyond the means of most families with kids threatened by possibly fatal allergic reactions.

At the same time, Bresch has seen her own compensation increase a whopping 671 percent, from $2,453,456 in 2007 (the year that Mylan bought EpiPen) to $18,931,068 in 2015.

She should resign for price gouging rather than get a raise, but like so many of her fellow executives Bresch sails serenely on as her fellow Americans drown in health care debt. Her career and the success of her company epitomize everything that so enrages every voter who believes that the fix is in and that the system is weighted in favor of those with big money and serious connections.

According to reports, Bresch got her first job at Mylan working in the factory basement, when her well-connected dad asked the company’s then-CEO, Milan Puskar, for a favor. Later, a scandal erupted when it was discovered that West Virginia University, which had received a $20 million donation from Puskar and whose president was a Manchin and Bresch family friend, had awarded her an MBAalthough she had not completed the required coursework.

The school president and other administrators were forced to resign, but Bresch survived the controversy and has done very well indeed in the pharmaceutical business, rising through the ranks and at the same time learning how to adroitly manipulate government and its regulations — lessons for which life in a successful political family with its network of friends and colleagues prepared her well.

For a time, she was Mylan’s chief lobbyist (working to help pass the 2003 Medicare prescription drug bill, among other legislation) and Anna Edney at Bloomberg Politicswrites that “Mylan spent about $4 million in 2012 and 2013 on lobbying for access to EpiPens generally and for legislation, including the 2013 School Access to Emergency Epinephrine Act, according to lobbying disclosure forms filed with the Office of the Clerk for the House of Representatives. Mylan also was the top corporate sponsor of a group called Food Allergy Research & Education that was the key lobbyist pushing for the bill encouraging schools to stock epinephrine auto-injectors, of which EpiPen is by far the leading product.”

The company also took advantage of what President Obama has called an “unpatriotic tax loophole,” making a deal in 2014 with Abbott Laboratories to incorporate in the Netherlands — one of those infamous “inversions” that allow companies to pay a much lower tax rate abroad than here at home — even as they rake in profits from U.S. taxpayer-subsidized programs like Medicare, Medicaid and veterans’ benefits. Political expedience and maybe embarrassment saw Joe Manchin denouncing his daughter’s inversion deal. But no one stopped it.

Like so many businesses eager to purchase politicians all their own, Mylan has made significant cash contributions to both sides of the aisle. Emmarie Huetteman at The New York Times reports, “Mylan’s political action committee has given at least $71,000 to congressional candidates from both parties this election cycle, according to the Center for Responsive Politics, with about 72 percent of those contributions going to Republicans.”

Dad got a taste, too: “It has been one of the biggest donors to Mr. Manchin since he joined the Senate in 2010, giving more than $60,000 in total.”

[Source:-Salon]

and big business Congress drugs EpiPen privilege: the 2016-08-31
Tags and big business Congress drugs EpiPen privilege: the
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Saheli
Previous Article :

Weak eurozone inflation raises prospect of ECB action – business live

Next Article :

Cigarettes, asbestos, now fossil fuels. How big business impacts public health

Related Articles

Swiggy Case Study: How One Startup Redefined Food Delivery in India

admin 30 Apr 2026

Three Simple Changes That Can Boost Productivity in Virtual Teams

admin 13 Mar 2026
Step up: Tips for organizations from the FTC’s settlement with Genshin Effect designer HoYoverse

Step up: Tips for organizations from the FTC’s settlement with Genshin Effect designer HoYoverse

admin 07 Feb 2025

Latest Post

Technology Companies Step Up Hiring for AI Agent Development and Deployment
Technology

Technology Companies Step Up Hiring for AI Agent Development and Deployment

admin 20 Nov 2026
Beyond Your Apartment: Why a Strong Community Is Your Best Real Estate Investment
Real Estate

Beyond Your Apartment: Why a Strong Community Is Your Best Real Estate Investment

admin 19 Nov 2026
Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025
Home Deco

Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025

admin 16 Nov 2026
Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection
Health

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

admin 16 Nov 2026
The Best Healthy Living Blogs of 2020
Health

The Best Healthy Living Blogs of 2020

admin 05 Nov 2026
Can Men Hold Off on Treating Recurring Prostate Cancer?
Health

Can Men Hold Off on Treating Recurring Prostate Cancer?

admin 04 Nov 2026
Migraine or Just a Bad Headache? How to Tell the Difference
Health

Migraine or Just a Bad Headache? How to Tell the Difference

admin 31 Oct 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme